Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age Related Macular Degeneration (ARMD)”

2,027 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,027 results

Testing effectiveness (Phase 2)Study completedNCT02140151
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Southern California Desert Retina Consultants, MC 108
Not applicableNo Longer AvailableNCT00349739
What this trial is testing

Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

Who this might be right for
Macular Degeneration
University of Iowa
Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Not applicableUnknownNCT05497128
What this trial is testing

Standard Cut Rate 27-Gauge System Versus Ultrahigh-Speed 27-Gauge System in Macular Surgery

Who this might be right for
Macular Disease
Seoul National University Bundang Hospital 66
Not applicableLooking for participantsNCT03921931
What this trial is testing

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

Who this might be right for
Macular Degeneration, DryPrimary Open-angle Glaucoma
Medical University of Vienna 35
Not applicableLooking for participantsNCT06375239
What this trial is testing

Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration

Who this might be right for
Retinitis PigmentosaChoroideremiaStargardt Macular Dystrophy+4 more
Ray Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Enrolling By InvitationNCT03999801
What this trial is testing

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
AbbVie 865
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Not applicableStudy completedNCT05456581
What this trial is testing

Scotoma Perimetry Oculomotor Training

Who this might be right for
Macular DegenerationCentral Visual Impairment
University of Alabama at Birmingham 21
Not applicableUnknownNCT04907409
What this trial is testing

Home OCT Fluid Visualization Agreement Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Notal Vision Inc. 120
Testing effectiveness (Phase 2)Study completedNCT02314299
What this trial is testing

MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaAge-related Macular Degeneration
Stealth BioTherapeutics Inc. 20
Testing effectiveness (Phase 2)WithdrawnNCT00696592
What this trial is testing

Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Padova
Not applicableNot Yet RecruitingNCT06943599
What this trial is testing

Strategies for Improving Linkage-to-Care After Eye Disease Screening

Who this might be right for
Age Related Macular DegenerationDiabetic RetinopathyGlaucoma
University of California, San Francisco 3,000
Testing effectiveness (Phase 2)Study completedNCT01571232
What this trial is testing

Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema

Who this might be right for
Diabetic Macular EdemaNon-proliferative Diabetic RetinopathyProliferative Diabetic Retinopathy
Retina Macula Institute 20
Not applicableStudy completedNCT02291887
What this trial is testing

Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

Who this might be right for
Age-Related Macular Degeneration
Associated Retinal Consultants, Michigan 13
Testing effectiveness (Phase 2)Study completedNCT02181504
What this trial is testing

Abicipar Pegol in Japanese Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 25
Testing effectiveness (Phase 2)Study completedNCT04486963
What this trial is testing

A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects

Who this might be right for
Age-related Macular Degeneration
Tasly Pharmaceutical Group Co., Ltd 78
Not applicableLooking for participantsNCT02253030
What this trial is testing

OCT Angiography in Wet AMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Oregon Health and Science University 160
Large-scale testing (Phase 3)Ended earlyNCT03577899
What this trial is testing

Efficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-1)

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 1,157
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Load More Results